Bispecific Antibodies Market to Reach USD 20.14 Billion by 2033, Driven by Rising Cancer Burden and Advancements in Dual-Target Therapies
Pune, India – April 21, 2026 — The global bispecific antibodies market is poised for significant expansion, with its valuation expected to grow from USD 5.51 billion in 2024 to USD 20.14 billion by 2033, reflecting a compound annual growth rate (CAGR) of 15.49% during the forecast period (2025–2033). This growth is largely fueled by increasing cancer incidence,...
0 Comentários 0 Compartilhamentos 114 Visualizações 0 Anterior